https://acpinternist.org/weekly/archives/2010/06/22/1.htm. Diabetes and cancer links evaluatedMedicare cuts raised chemotherapy treatments, changed drug choices. ... Epidemiologic data have shown a higher risk for some cancers among diabetes patients,
It was approved under the FDA's priority review program. Linagliptin (Tradjenta) tablets to treat type 2 diabetes, along with diet and exercise. ... It should not be used to treat people with type 1 diabetes or diabetic ketoacidosis.
Albiglutide (Tanzeum) to treat type 2 diabetes in adults, along with diet and exercise. ... treat type 1 diabetes or diabetic ketoacidosis, or as a first-line therapy.
https://acpinternist.org/weekly/archives/2022/05/24/2.htm. In a small trial, patients with insulin-treated diabetes were randomly assigned to usual care, a lottery incentive for daily ... Additional support and incentives for digital self-monitored blood
The guidance statement shouldn't be taken to think ACP is relaxing on diabetes,” he said. ... Kirkman, medical director of the University of North Carolina Diabetes Care Center clinical trials unit in Chapel Hill.
https://acpinternist.org/weekly/archives/2013/07/02/1.htm. CHICAGO—Long-term effects of lifestyle modification and hospitalization rates for complications of diabetes and diabetes treatment were among the research ... Finally, an analysis of
Higher-dose statin therapy increased patients' risk of developing diabetes more than moderate-dose regimens, a new meta-analysis found. ... The trials had 32,752 participants, all of whom were without diabetes at baseline.
Research indicates that risk for heart failure in patients with diabetes increases with HbA1c level, Dr. ... Mitchell. “Certainly the treatment of diabetes is relevant to all specialties,” she said.
Angiotensin-converting enzyme (ACE) inhibitors were found to possibly improve outcomes for patients with diabetes more than other antihypertensives, a recent meta-analysis found. ... In the systematic review and Bayesian network meta-analysis,
These results should reassure physicians treating patients at low risk for diabetes,” the authors wrote. ... Many patients with established vascular disease, such as those in this study, will die from an atherosclerotic event before they develop